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Abstract 
Aim: To test whether guided bone regeneration (GBR) of peri-implant defects at 
zirconia (ZrO2) implants differs from GBR at titanium (Ti) implants regarding the bone 
integration of the implant and of the grafting material. 
Material and methods: Maxillary premolars and molars were extracted in 7 dogs. 
After  5 months, four semi-saddle bone defects were created in each maxilla. Implant 
placement and simultaneous GBR was performed using the following randomly assigned 
modalities: (1) ZrO2 implant + deproteinized bovine bone mineral (DBBM) granules + a 
collagen membrane (CM), (2) ZrO2 implant + DBBM with 10% collagen matrix + CM, (3) ZrO2 
implant + DBBM block + CM, and (4) Ti implant + DBBM granules + CM. After 3 months, one 
central histological section of each site was prepared. Histomorphometrical assessments 
were performed evaluating the augmented area (AA) within the former bone defect (primary 
outcome), the area of new bone (NB), bone substitute (BS), and non-mineralized tissue 
(NMT) within AA in mm2. In addition, the distance between the most coronal bone-to-implant-
contact and the margin of the former bone defect (fBIC-DEF), and the bone-to-implant 
contact fraction (BIC) were measured in mm. 
Results: AA measured 8.6±4.0 mm2 for ZrO2 implant+DBBM granules, 4.7±1.6 mm2 
for ZrO2 implant+DBBM/collagen, 5.1±1.9 mm2 for ZrO2 implant+DBBM block, and 7.6±2.8 
mm2 for Ti implant+DBBM granules. There were no statistically significant differences 
between the treatment modalities (P>0.05). NB reached 2.0±1.7 mm2 for ZrO2 
implant+DBBM granules, 0.9±0.9 mm2 for ZrO2 implant+DBBM/collagen, 2.1±0.9 mm2 for 
ZrO2 implant+DBBM block, and 0.8±0.6 mm2 for Ti implant+DBBM granules. fBIC-DEF 
amounted  to 2.1±1.7 mm2 for ZrO2 implant+DBBM granules, to 2.7±1.1 mm2 for ZrO2 
implant+DBBM/collagen, to 2.9±1.2 mm2 for ZrO2 implant+DBBM block, and to 3.4±0.4 mm2 
for Ti implant+DBBM granules. BIC measured 70±19 % for ZrO2 implant+DBBM granules, 
69±22 % for ZrO2 implant+DBBM/collagen, 77±30 % for ZrO2 implant+DBBM block, and 
66±27 % for Ti implant+DBBM granules.  
Conclusions: The findings of the present pilot study suggest that zirconia and 
titanium implants grafted with DBBM granules and covered with a collagen membrane do not 
perform differently regarding the augmented ridge contour, the new bone formation and the 
implant osseointegration. 
 
 
 
 
 
Introduction 
Ceramic dental implants made of zirconium dioxide (zirconia) were brought to the 
market as an alternative to metal implants made of titanium and titanium-alloys. The clinical 
use of zirconia implants is currently increasing due to the general trend for metal-free 
solutions and tooth-colored reconstruction materials.  
Previous investigations demonstrated the high biocompatibility and the promising 
mechanical properties of zirconia, such as high fracture toughness, high flexural strength 
and hardness, resistance to corrosion, and low thermal conductivity (Hisbergues et al. 2009) 
(Ichikawa et al. 1992; Kohal et al. 2009; Piconi et al. 1998). Several animal studies did not 
find differences in the degree of osseointegration between zirconia and titanium implants 
under different loading conditions (Gahlert et al. 2012; Gahlert et al. 2009; Koch et al. 2010; 
Kohal et al. 2004; Schliephake et al. 2010; Stadlinger et al. 2010; Thoma et al. 2015). A 
recent systematic review analyzed the preclinical investigations of the bone-to-implant 
contact (BIC) values of zirconia and titanium implants (Manzano et al. 2014). The review 
included 19 studies and concluded that in most of the trials BIC values did not significantly 
differ between zirconia and titanium implants. 
Despite the existence of several commercially available zirconia implant systems, not 
many clinical studies documenting the use of zirconia implants are available yet. Recent 
clinical trials investigating zirconia implants found successful tissue integration and high 
survival rates after short-term observation periods (Cannizzaro et al. 2010; Jung et al. 2016; 
Kohal et al. 2012; Kohal et al. 2013; Oliva et al. 2010; Payer et al. 2013; Payer et al. 2015). 
In one prospective study, the investigated zirconia implant fulfilled the success criteria that 
have been proposed for titanium implants (Albrektsson & Isidor 1993; Jung et al. 2016). 
Guided bone regeneration (GBR) procedure is routinely performed in daily practice to 
regenerate missing hard tissue volume prior to or simultaneously with implant placement 
(Benic & Hammerle 2014). There is a large body of clinical evidence documenting that 
survival rates of titanium implants placed in conjunction with GBR are similar to those of 
titanium implants placed into native bone (Benic et al. 2009; Jung et al. 2013; Zitzmann et al. 
2001; Zumstein et al. 2012). Currently, the application of xenografts in combination with 
resorbable collagen membranes is the most widely used and well-documented method for 
the augmentation of peri-implant defects (Chiapasco & Zaniboni 2009; Jensen & Terheyden 
2009). GBR with particulate xenograft and collagen membrane renders high percentage of 
apico-coronal defect fill and long-term stability of the augmented hard tissue (Buser et al. 
2013; Jung et al. 2015). Moreover, it was demonstrated that GBR of peri-implant bone 
defects renders a long-term stable increase in the peri-implant mucosal contour (Benic et al. 
 
 
2016a). However, to date, there is very little preclinical and clinical evidence documenting 
the use of GBR concomitant with the placement of zirconia implants.  
Therefore, the primary aim of the present pilot study was to test whether or not GBR 
of peri-implant defects at zirconia implants by means of xenogenic bone substitutes and 
collagen membranes differs from GBR at titanium implants with regard to hard tissue 
integration of the implant and of the grafting material. Moreover, at zirconia implants different 
particulate and non-particulate bone substitutes were compared for GBR in combination with 
collagen membranes. 
 
 
 
Materials and methods 
This article was written in accordance with the ARRIVE (Animal research: Reporting 
of in vivo experiments) guidelines (Kilkenny et al. 2010).  
Animals 
Seven male adult beagle dogs (age 20 ± 3 months, mean weight 16.8 kg) 
(Isoquimen, Barcelona, Spain) were included in this trial. All animals presented a fully 
erupted permanent dentition.  
The animals were subjected to surgeries and housed in the Animal Experimentation 
Service Facility at the Veterinary Hospital Rof Codina, Lugo, Spain. Prior to the start of the 
study, the experimental protocol was approved by the Ethical Committee Rof Codina 
Foundation. All the procedures were performed according to Spanish and European Union 
regulations about care and use of research animals. The dogs were monitored daily for the 
duration of the study by a veterinarian accredited in laboratory animal science. The animals 
were housed in a group kennel with indoor and outdoor areas. The indoor area presented a 
controlled temperature of 20–22°C with natural light and air renewal. During the study period, 
the animals received a soft-food diet and water ad libitum. The trial started after a 3-week 
adaption period for the animals.  
 
Study design and randomization  
This investigation was designed as a randomized controlled trial with intra-subject 
control for the comparison of four treatment modalities. The study was performed in two 
surgical phases including (1) tooth extraction and (2) implant placement with simultaneous 
GBR of acute-type peri-implant bone defects (four defects per animal).  
The experimental sites were randomly allocated to one of the four treatment 
procedures according to a computer-generated randomization list. Allocation to the treatment 
was concealed by means of sealed envelopes until the time of the GBR procedure.  
 
Surgical procedures  
The investigators participating in the study were experienced in implant placement 
and guided bone regeneration procedures. The surgical part of this study was conducted 
from October 2011 to May 2012. 
All surgical procedures were performed under general anesthesia of the animals. The 
dogs were pre-medicated with medetomidine (20 μg/kg/i.m.; Esteve, Barcelona, Spain) and 
morphine (0.4 mg/kg/i.m., Morfina Braun 2%; B. Braun Medical, Barcelona, Spain). The 
 
 
anesthesia was initiated by propofol (2 mg/ kg/i.v.; Propovet, Abbott Laboratories, Kent, UK), 
and maintained by inhalation of an O2 and 2.5-4% isoflurane mixture (Isobavet, Schering-
Plough, Madrid, Spain). A local anesthesia composed of lidocaine and adrenaline (Anesvet®, 
Ovejero, Leon, Spain) was used to reduce peri-operative pain and bleeding. During 
anesthesia, the dogs were monitored by a veterinarian, applying electrocardiography, 
capnography, pulsioxymetry, and blood pressure measurements. After the surgery, 
atipamezol (50 μg/kg/i.m.; Esteve) was administered to revert the effects of the 
medetomidine.  
Postoperatively, pain was controlled with morphine (0.3 mg/kg/i.m.) for 24 h and, 
subsequently, with meloxicam (0.1 mg/kg/ s.i.d/p.o.; Metacam, Boehringer Ingelheim, 
Barcelona, Spain) for 3 days. Antibiotics (amoxicillin 22 mg/kg/s.i.d./s.c.; Amoxoil retard, 
Syva, Leon, Spain) were administrated for 7 days.  
During the first two postoperative weeks, the oral mucosa and the teeth were 
disinfected three times a week by using gauzes soaked in a 0.12% chlorhexidine solution 
(Perio-Aid Tratamiento®, Dentaid, Barcelona, Spain). Subsequently, a toothbrush and a 0.2% 
chlorhexidine gel (Chlorhexidine Bioadhesive Gel, Lacer, Barcelona, Spain) were used for 
plaque control.  
Surgery 1 (tooth extraction)  
The maxillary second, third and fourth premolars (P2, P3, P4) and first molars (M1) 
were bilaterally sectioned by using fissure burs and extracted with dental elevators and 
forceps. Mucosal margins were adapted by means of resorbable sutures (Vicryl® 5-0, 
Ethicon, Issy Les Moulineaux Cedex, France).  
Surgery 2 (defect preparation, implant placement, and GBR)  
Preparation of defects, implant placement and GBR of peri-implant bone defects 
were conducted 5 months after tooth extraction. Following a mid-crestal incision from the 
region of P2 to M2 and a vertical releasing incision in the region of P2, the mucoperiosteal 
flaps were elevated. The coronal portion of the edentulous ridge was flattened in the region 
of P4 and M1.  
On each side of the maxilla, two implant beds with a diameter of 4 mm were prepared 
3 mm from each other and 2 mm lingual to the buccal wall of the alveolar ridge. 
Subsequently, a standardized semi-saddle-type bone defect was prepared at each implant 
bed by removing the buccal wall of the alveoloar ridge. The bone defects measured 4 mm 
mesio-distally, 4 mm apico-coronally, and 2 mm bucco-orally (Fig. 1). All the osteotomy 
procedures were performed under irrigation with sterile 0.9% saline.  
 
 
 
Three test zirconia bone level implants and one control titanium bone level implant 
were placed in each maxilla obtaining primary stability. A prototype bone level implant made 
of yttrium-stabilized zirconia was used in this study (vitaclinical, VITA Zahnfabrik, Bad 
Säckingen, Germany). The surface morphology of the zirconia implant was created by 
sandblasting, acid etching with hydrofluoric acid, and subsequent annealing. The obtained 
surface roughness was in the range of Ra = 1.2 µm (Fischer et al. 2016). Titanium bone level 
implant was used as control (OsseoSpeedTM S, ASTRA TECH Implant System, DENTSPLY 
Implants, Mannheim, Germany). All the implants exhibited a diameter of 4 mm and a length 
of 8 mm. The apico-coronal position of the implant shoulder coincided with the most coronal 
level of the palatal bone wall (Fig. 1). Titanium closure screws (DENTSPLY Implants) were 
placed on the titanium implants. 
The defects were randomly allocated to receive one of the following treatments (Fig. 
2):  
• ZrO2 implant+DBBM granules: zirconia implant (vitaclinical) + particulated 
deproteinized bovine bone material (DBBM) (Bio-Oss® granules 0.25-1 mm, 
Geistlich Pharma AG, Wolhusen, Switzerland) + a non-cross-linked porcine 
collagen membrane (CM) (Bio-Gide®, Geistlich Pharma AG)  
• ZrO2 implant+DBBM-collagen: zirconia implant (vitaclinical) + DBBM with collagen 
matrix (Bio-Oss® collagen, Geistlich Pharma AG)  + CM  
• ZrO2 implant+DBBM block: zirconia implant (vitaclinical) + DBBM cancellous 
block: (Bio-Oss® spongiosa block, Geistlich Pharma AG) + CM  
• Ti implant+DBBM granules: titanium implant (DENTSPLY Implants) + particulated 
DBBM + CM 
The bone substitutes were applied to achieve 1 mm of over-contour with respect to 
the buccal surface of the alveolar ridge. The DBBM blocks and DBBM-collagen were 
individually shaped and adapted to fit the bone defects. Prior to the application, all bone 
substitutes were hydrated with sterile 0.9% saline. CM was applied to cover the bone 
substitute and overlap the walls of the defect by at least 2 mm (Fig. 2). No screws or pins for 
stabilization of blocks and membranes were used. 
The periosteum of the buccal flap was relieved along its base, and primary wound 
closure was accomplished by placing horizontal mattress and interrupted sutures made of 
ePTFE (Gore-Tex® sutures 5-0; W.L. Gore & Associates Inc., Flagstaff, AZ, USA). The 
sutures were removed after 2 weeks.  
 
 
 
Retrieval of specimens  
Three months after implant placement and GBR, the animals were sedated with 
medetomidine (30 μg /kg/i.m.; Esteve) and subsequently killed with an overdose of sodium 
pentobarbital (40–60 mg/kg/i.v., Dolethal, Vetoquinol, France). The maxillae were dissected, 
and the experimental specimens were retrieved with intact soft tissues.  
 
Histological preparation  
Fixation of the specimens was performed in buffered 4% formaldehyde solution. The 
specimens were dehydrated using ethanol solutions of increasing concentrations and 
subsequently embedded in a methyl methacrylate resin (Sigma-Aldrich M55909-1L, Sigma-
Aldrich, Buchs, Switzerland). Radiographs were taken of each site to accurately determine 
the section planes. One bucco-oral section through the central axis of the implant was 
prepared from each site. The tissue blocks were cut into 200-µm-thick sections using a 
diamond band saw (Exakt Apparatebau, Norderstedt, Germany). The sections were ground 
and polished to a thickness of 60-80 µm (Exakt Apparatebau) (Donath & Breuner 1982). The 
sections were stained with toluidine blue (Schenk et al. 1984) (Fig. 3). 
 
Histomorphometric analysis  
 
Histomorphometrical analysis was performed by one investigator that was unaware of 
the specific experimental conditions. A light microscope (Microscope Leica DM6000, Leica 
Mikrosysteme, Wetzlar, Germany) connected with a digital color camera (Leica DFC 450 
(Leica Mikrosysteme) was used for image capturing. For histomorphometrical analysis, 
digital images were evaluated using an image analysis software (Leica Application Suite 
V4.3, Leica Mikrosysteme). 
The following reference points were identified on the buccal surface of each implant: 
the implant shoulder (IS), the most coronal level of bone in contact with the implant (fBIC) 
and the apical margin of the former bone defect (DEF). 
For each section, the following variables were assessed:  
• the augmented area (AA) (mm2) within the former bone defect at the buccal 
aspect (primary outcome) (Fig. 4) 
• the area of new mineralized bone (NB) (mm2), residual bone substitute (BS) 
(mm2), and non-mineralized tissue (NMT) (mm2) within AA  (Fig. 4) 
 
 
• the apico-coronal distance between the most coronal level of bone in contact with 
the implant and the apical margin of the former bone defect (fBIC-DEF) (Fig. 5) 
• bone-to-implant contact fraction (BIC) (%) in the 2 mm-long region-of-interest 
apical to the margin of the former bone defect. 
 
Statistical analysis 
The animal was chosen as the unit for the statistical analysis. The data were reported 
by using means, standard deviations (SD), ranges, 95% confidence intervals (CI), medians, 
and interquartile ranges (IQR) (SPSS software; SPSS Inc., Chicago, IL, USA). The Wilcoxon 
signed rank test was applied to detect differences between the treatments (R software; R 
Foundation, Vienna, Austria). The results of tests with P-values ≤0.05 were considered 
statistically significant. Due to the exploratory nature of this study, no sample size calculation 
and no correction for multiple testing were performed. 
 
 
 
 
Results 
All animals remained healthy during the study period and no adverse events were 
observed. One histological specimen from the ZrO2 implant+DBBM-collagen and one 
specimen from the ZrO2 implant+DBBM block groups were excluded from the analysis due to 
the erroneous placement of the histologic section. One ZrO2 implant augmented with 
DBBM/collagen did not integrate and it was excluded from the analysis. A total of 7 ZrO2 
implant+DBBM granules, 5 ZrO2 implant+DBBM/collagen, 6 ZrO2 implant+DBBM block, and 
7 Ti implant+DBBM granules sites were available for the histomorphometrical analysis. 
Augmented area (AA) amounted to 8.6 ± 4.0 mm2 (SD) for ZrO2 implant+DBBM 
granules, 4.7 ± 1.6 mm2 (SD) for ZrO2 implant+DBBM-collagen, 5.1 ± 1.9 mm2 (SD) for ZrO2 
implant+DBBM block, and 7.6 ± 2.8 mm2 (SD) for Ti implant+DBBM granules. The sites 
augmented with DBBM granules resulted in higher mean values in comparison to the sites 
treated with DDBM/collagen and DBBM block. There were, however, no statistically 
significant differences between the treatment modalities (P > 0.05) (Table 1, Fig. 6). 
New mineralized bone (NB) measured 2.0 ± 1.7 mm2 (SD) for ZrO2 implant+DBBM 
granules, 0.9 ± 0.9 mm2 (SD) for ZrO2 implant+DBBM-collagen, 2.1 ± 0.9 mm2 (SD) for ZrO2 
implant+DBBM block, and 0.8 ± 0.6 mm2 (SD) for Ti implant+DBBM granules (Table 1, Fig. 
6). 
Residual bone substitute (BS) reached 2.3 ± 1.6 mm2 (SD) for ZrO2 implant+DBBM 
granules, 1.9 ± 1.7 mm2 (SD) for ZrO2 implant+DBBM-collagen, 1.0 ± 0.6 mm2 (SD) for ZrO2 
implant+DBBM block, and 2.4 ± 1.6 mm2 (SD) for Ti implant+DBBM granules. The sites 
augmented with DBBM granules reached higher mean values than the sites treated with 
DBBM/collagen and DBBM block (Table 1, Fig. 6). 
With regard to the distance between the most coronal level of bone in contact with 
the implant and the apical margin of the former bone defect (fBIC-DEF), the values 
amounted to 2.1 ± 1.7 mm2 (SD) for ZrO2 implant+DBBM granules, to 2.7 ± 1.1 mm2 (SD) for 
ZrO2 implant+DBBM-collagen, to 2.9 ± 1.2 mm2 (SD) for ZrO2 implant+DBBM block, and to 
3.4 ± 0.4 mm2 (SD) for Ti implant+DBBM granules (Table 1). 
Bone-to-implant contact measured 70 ± 19 % (SD) for ZrO2 implant+DBBM granules, 
69 ± 22 % (SD) for ZrO2 implant+DBBM-collagen, 77 ± 30 % (SD) for ZrO2 implant+DBBM 
block, and 66 ± 27 % (SD) for Ti implant+DBBM granules (Table 1).  
 
 
Discussion 
The results of the present study indicated that the application of DBBM granules and 
CM for GBR of peri-implant defects at zirconia implant did not differ from GBR at titanium 
implants with regard to the implant osseointegration, the dimension of the augmented ridge, 
and the new bone formation. For peri-implant defects at zirconia implants, the application of 
DBBM granules and CM resulted in higher mean width of the ridge in comparison to the use 
of DBBM-collagen and DBBM blocks in combination with CM. Due to the exploratory nature 
of the present trial with small sample size, these findings need to be interpreted with caution. 
The findings regarding the osseointegration of zirconia and titanium implants from 
the present study are in accordance with previous investigations. Several animal studies did 
not find differences in the amount of osseointegration between zirconia and titanium implants 
under different loading conditions (Gahlert et al. 2012; Gahlert et al. 2009; Koch et al. 2010; 
Kohal et al. 2004; Schliephake et al. 2010; Stadlinger et al. 2010; Thoma et al. 2015). A 
recent systematic review included 19 preclinical histologic investigations of the bone-to-
implant contact at zirconia and titanium implants (Manzano et al. 2014). It was concluded 
that in most of the trials bone-to-implant contact values did not differ between zirconia and 
titanium implants. 
In the present study, the apico-coronal distance between the most coronal bone-to-
implant contact and the apical wall of the former bone defect was measured. The 
assessment of bone growth along the originally exposed implant surface can be interpreted 
as a measure of vertical osteoconductivity of the implant surface. The bone growth along 
the exposed buccal surface of the titanium implant reached in average more coronal levels in 
comparison to the zirconia implants. To our knowledge, this is the first trial comparing the 
osteogenic surface properties of the exposed zirconium and titanium implants. 
With respect to the dimension of the augmented ridge, GBR with DBBM granules and 
CM at zirconia implants did not differ from GBR at titanium implants. In contrast, the mean 
values of the ridge contour at zirconia implants differed when comparing particulate and 
non-particulate grafting materials. Particulate DBBM in combination with CM reached the 
highest mean value in ridge dimensions, followed by DBBM block and DBBM-collagen in 
combination with CM. The higher mean dimension of the ridge augmented with particulate 
DBBM was due to the higher amount of residual bone substitutes and non-mineralized 
tissue. Based on this finding, it can be deduced that the contour of the augmented ridge was 
mainly influenced by the properties of the grafting materials used for GBR.  
In all the experimental sites, no complete augmentation of the initial bone defect 
could be achieved. This result could be partially explained by the displacement of the 
 
 
mechanically unstable grafting materials and collagen membranes during the healing period. 
It is known that particulated bone substitutes in combination with CM are sub-optimal for the 
augmentation of non-contained bone defects due to the unfavorable mechanical properties 
with low resistance to pressure and thus a risk for collapse (Benic et al. 2016; Schwarz et al. 
2007; Strietzel et al. 2006; Zellin et al. 1995). In this context, it is surprising that sites 
augmented with DBBM blocks and DBBM-collagen resulted in lower mean values in ridge 
contour compared to the sites augmented with particulated DBBM.  
The low value of the augmented area achieved with DBBM block in combination with 
CM can be partially explained by the intra- and post-operative fractures of DBBM blocks and 
subsequent displacement of the block fragments. Intra-operatively, DBBM block was prone 
to fractures, thereby not permitting “press-fit” adaptation and mechanical anchorage within 
the box-shaped defects. In a recent in-vitro study, the volume stability of particulated and 
block bone substitutes in combination with CM for GBR of peri-implant defects was 
investigated by means of cone-beam computed tomography (CBCT) (Mir-Mari et al. 2016b). 
It was found that wound closure and flap suturing always induced a considerable 
displacement of the particulated grafting material resulting in a partial collapse of the CM. In 
contrast, the sites augmented with block bone substitutes exhibited less collapse of the 
membranes. The investigators concluded that the ability to maintain the contour of the 
augmented region during wound closure and flap suturing was significantly enhanced when 
using a block bone substitute in comparison to GBR with particulated material. These 
findings were confirmed by an animal study that was designed to assess the performance of 
xenogenic blocks and granules (Benic et al. 2016). In this study, equine-derived blocks, 
DBBM blocks and particulated DBBM were used in combination with CM for GBR of large 
peri-implant defects. The equine-derived bone block substitute in combination with CM 
reached the highest mean values in ridge dimensions, followed by DBBM block and DBBM 
granulate in combination with CM. A comparison of particulated and block DBBM for 
horizontal augmentation of chronic-type bone defects was performed in another preclinical 
study (Schwarz et al. 2008). In this trial, the bone substitute and CM were used alone or with 
an addition of growth factors. After 3 and 8 weeks, samples were prepared for histological 
analysis. When assessing the width of the augmented ridge, block of DBBM stabilized by 
titanium screws appeared to perform better in comparison with particulated DBBM. The 
results of these studies are not in accordance with the findings regarding GBR with DBBM 
block from the present trial. The differences in the results between the trials may be 
explained by the different localization and size of the experimental defects. 
In the present study the lowest mean value of the augmented ridge was achieved by 
DBBM-collagen. This composite material consists of 90% DBBM particles embedded in a 
10% resorbable collagen matrix of porcine origin. The addition of collagen aims to facilitate 
 
 
the clinical handling and to achieve a stabilization of the graft (Wong & Rabie 2010). The 
influence of the mechanical stability of DBBM-collagen on the performance of GBR of peri-
implant defects was investigated in a recent in-vitro study (Mir-Mari et al. 2016a). This study 
tested whether GBR with DBBM-collagen in addition to the DBBM granules differs from GBR 
with DBBM granules with regard to the volume stability of the augmented region during flap 
closure. The investigators concluded that the addition of DBBM-collagen soft-type block to 
DBBM granules, covered by CM and fixed with pins, significantly improved the horizontal 
volume stability of the augmented region during wound closure. The findings of this in-vitro 
study are in contradiction with results from the present trial. The poor result in the 
maintenance of the augmented ridge with DBBM-collagen from the present study could be 
explained by the biodegradation of the collagen matrix and a subsequent displacement of 
the DBBM particles. It is striking that, even though DBBM-collagen has been widely used for 
different clinical indications, there is insufficient evidence regarding the use of DBBM-
collagen for GBR of peri-implant defects. To our knowledge, there are no previous studies 
comparing the use of DBBM with and DBBM without collagen matrix for GBR of peri-implant 
defects regarding the volume stability of the augmented area. A recent randomized 
controlled trial compared the dimensional changes after ridge preservation with particulated 
DBBM and DBBM-collagen (Nart et al. 2016). CBCT were taken at tooth extraction and at 5 
months. Both treatments resulted in a significant ridge reduction in width and height. When 
comparing the treatment groups, although there were no statistically significant differences, 
DBBM group showed less dimensional changes compared to the DBBM-collagen group. 
While in the DBBM group ridge width decreased 0.91 mm, a mean reduction of 1.53 mm was 
measured in the DBBM-collagen group. These findings are in accordance with the results of 
the augmented ridge dimensions from the present study. 
Due to the small sample size and considerable variations of the data, the results of 
the present study have to be interpreted with caution. Another important limitation of the 
present trial is the lack of the negative control group. Consequently, it was not possible to 
assess the degree of the spontaneous bone healing at the experimental maxillary acute-type 
peri-implant defects. The model of an acute-type defect used in this study represents 
another methodological shortcoming, as this type of defect is not considered to adequately 
simulate the clinical reality. Nevertheless, this study provides valuable data on the bone 
integration of zirconia implants grafted with particulate and non-particulate bone substitutes 
for GBR. Further controlled clinical trials are needed to examine the clinical implications of 
the findings from the present preclinical study.  
 
 
Conclusions 
The findings of the present study suggest that for guided bone regeneration of peri-
implant bone defects: 
• Zirconia and titanium implants grafted with DBBM granules and covered with 
collagen membranes did not perform differently in terms of dimension of the 
augmented ridge, new bone formation and implant osseointegration. 
• For peri-implant defects at zirconia implants, the application of DBBM 
granules and collagen membranes revealed the most favorable results 
regarding the augmented ridge contour. 
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Figure legends 
Fig. 1. (a) Buccal and (b) occlusal views of the bone defects prior to guided bone 
regeneration.  
Fig. 2. (a, b, c) GBR procedures with particulate deproteinized bovine bone mineral 
(DBBM) (left) and DBBM with collagen matrix (right) in combination with collagen membrane 
at zirconia implants. (d, e, f) GBR procedures with particulate DBBM in combination with 
collagen membrane at titanium implant (control) (left) and block DBBM in combination with 
collagen membrane at zirconia implant. 
Fig. 3. Histological views (original magnification x12.5): (a) zirconia implant with 
particulated deproteinized bovine bone material (DBBM) and collagen membrane (CM), (b) 
zirconia implant with DBBM-collagen and CM, (c) zirconia implant with DBBM block and CM, 
and (d) titanium implant with particulated DBBM and CM. 
Fig 4. Histomorphometrical analysis of the augmented area (AA) within the former 
bone defect, the area of new mineralized bone (blue surface) within AA, and the area of 
residual bone substitute (red surface) within AA. 
Fig 5. (a) Histomorphometrical measurement of the distance between the most 
coronal level of bone in contact with the implant (fBIC) and the margin of the former bone 
defect (DEF) (original magnification x25). The red rectangle represents the extension of the 
following high-magnification image (b) The most coronal level of bone in contact with the 
buccal implant surface marked by the blue arrow (original magnification x500). 
Fig 6. Plots representing the mean values of the surfaces (in mm2) of new bone (NB), 
residual bone substitute (BS), and non-mineralized tissue (NMT) within the augmented area 
(AA) for different treatment modalities. The total sum of NB, BS and NMT corresponds to AA. 
 
 
 
Table legends 
Table. 1. Results of the (a) histomorphometrical analysis; (b) statistical tests for 
comparisons between the treatment modalities. 
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Figure 5 
 
 
 
(a)   Treatment 
modality 
      
Parame
ter 
Unit 1. ZrO2 
implant + 
DBBM 
granules  
(n=7) 
2. ZrO2 
implant + 
DBBM-
collagen 
(n=5) 
3. ZrO2 
implant + 
DBBM block        
(n=6) 
4. Ti implant 
+       DBBM 
granules  
(n=7) 
    Mean ± SD                 
(Q1, median, 
Q3) 
      
AA mm2 8.6 ± 4.0 4.7 ± 1.6 5.1 ± 1.9 7.6 ± 2.8 
    (4.9, 8.7, 
12.3) 
(3.2, 4.4, 6.4) (3.9, 5.7, 6.5) (4.5, 8.1, 
10.2) 
NB mm2 2.0 ± 1.7 0.9 ± 0.9 2.1 ± 0.9 0.8 ± 0.6 
    (0.6, 1.4, 4.3) (0.2, 0.3, 1.9) (1.3, 2.2, 2.9) (0.4, 0.5, 0.8) 
BS mm2 2.3 ± 1.6 1.9 ± 1.7 1.0 ± 0.6 2.4 ± 1.6 
    (1.2, 1.8, 4.4) (0.8, 1.6, 3.2) (0.6, 0.8, 1.5) (1.4, 1.6, 3.8) 
NMT mm2 4.2 ± 2.4 1.9 ± 1.7 2.4 ± 0.9 4.4 ± 1.4 
    (2.2, 4.4, 6.5) (0.9, 1.2, 3.2) (1.8, 2.3, 2.9) (3.0, 4.7, 5.7) 
DEF-
fBIC 
mm 2.1 ± 1.7 2.7 ± 1.1 2.9 ± 1.2 3.4 ± 0.4 
    (0.3, 1.5, 3.4) (1.8, 2.7, 3.6) (2.0, 2.7, 4.0) (3.2, 3.5, 3.7) 
BIC % 70 ± 19 69 ± 22 77 ± 30 66 ± 27 
    (52, 74, 79) (51, 62, 91) (42, 91, 100) (49, 59, 100) 
 
 
 
 
 
 
Figure 6 
